---
title: "Protein-metabolite association studies identify novel proteomic determinants of metabolite levels in human plasma"
description: |
  * **Approach**: A large-scale multi-omics resource was created by meta-analyzing proteomic and metabolomic data from three cohorts, followed by the use of **Mendelian Randomization (MR)** with **pQTLs** to infer causal relationships.
  * **Causal Findings**: The study identified **224 putative causal associations** between 95 proteins and 96 metabolites, including novel links like the causal role of **ADAMTSL3** in regulating **BCAA metabolites**.
  * **Validation**: Over 50% of the top causal findings were **experimentally validated** through metabolomic profiling of **mouse knockout strains**, providing strong biological proof for the in-silico MR results.
date: last-modified
categories: [causal inference, mendelian randomization, metabolomics, multi-omics, proteomics, systems biology]
---

**PubMed:** [37582364](https://pubmed.ncbi.nlm.nih.gov/37582364/)
**DOI:** [10.1016/j.cmet.2023.07.012](https://doi.org/10.1016/j.cmet.2023.07.012)
**Overview generated by:** Gemini 2.5 Flash, 27/11/2025

## Background and Objective

Circulating levels of **proteins and metabolites** in human plasma reflect the physiological state of an individual and are strongly associated with the risk of various complex diseases, particularly **cardio-metabolic disorders**. While many associations have been identified, distinguishing between **causal relationships** (where a protein concentration change directly causes a metabolite level change) and **confounded associations** (where both are affected by a third factor) remains a major challenge.

The primary objective of this study was to integrate **proteomic, metabolomic, and genomic data** using **Mendelian Randomization (MR)** to systematically identify **putative causal relationships** between circulating proteins and metabolites in human plasma.

## Study Methods and Data Integration

The study employed a large-scale, multi-stage, multi-omics approach:

1.  **Data Cohorts:** Quantitative proteomic (1,302 proteins) and metabolomic (365 metabolites) data were meta-analyzed across **three large population studies** (Jackson Heart Study, Multi-Ethnic Study of Atherosclerosis, and Health, Risk Factors, Exercise Training and Genetics), totaling 3,626 individuals.
2.  **Pairwise Association Analysis:** The study first identified **172,000 significant pairwise correlations** between proteins and metabolites across the three cohorts.
3.  **Causal Inference via Mendelian Randomization (MR):** To overcome confounding, **two-sample MR** was applied using **genetic instruments** derived from **protein-quantitative trait loci (pQTLs)**, specifically those located near the coding region of 535 proteins. These genetic variants served as instrumental variables to assess the **causal effect** of protein levels (exposure) on metabolite levels (outcome).
4.  **Meta-Analysis and Validation:** Causal estimates were meta-analyzed across the three studies. Sensitivity analyses (MR-Egger, weighted median) were performed to check for robustness against pleiotropy.
5.  **In Vivo Validation:** To provide biological proof-of-concept, the top-ranking protein-to-metabolite causal associations were validated in vivo using **metabolomic profiling of mouse knockout strains** for the corresponding genes.

## Key Results and Findings

### Causal Protein-Metabolite Associations
* The MR analysis identified **224 putative causal associations** between 95 proteins and 96 metabolites.
* **Novel Findings:** Many of these causal links were novel, offering new insights into metabolic regulation. For instance, the study confirmed the causal role of **Apolipoprotein C-III (ApoC3)** in increasing **triglycerides** but also identified novel links, such as the causal role of **protein ADAMTSL3** in regulating several plasma metabolites, particularly **branched-chain amino acid (BCAA) metabolites**.

### Validation of Causal Links
* **In Vivo Confirmation:** Over **50% of the tested protein-to-metabolite causal associations** were successfully validated in the mouse knockout models, providing strong experimental support for the causal nature of the in-silico findings. For example, knocking out the gene encoding the protein CSHL1 resulted in predicted changes in specific metabolites, validating the MR findings.

### Network and Pathway Insights
* The study confirmed known metabolic hubs but also identified novel networks where proteins regulate metabolites. Many of the causal links highlighted pathways relevant to **lipid metabolism** and **amino acid catabolism**, known drivers of cardio-metabolic risk.

## Conclusions and Significance

This research successfully established a robust **multi-omics-to-causality pipeline** by integrating large-scale human proteomic, metabolomic, and genomic data. By using Mendelian Randomization and subsequent *in vivo* validation, the study identified **224 high-confidence protein-to-metabolite causal associations**.

These findings significantly advance the understanding of the molecular determinants of metabolic traits, providing a valuable resource for identifying novel **therapeutic targets** for cardiovascular and metabolic diseases.